Lupin Q3 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
1,953.55
28.80 (1.50%)
28.80 (1.50%)Volume17.71 K
Updated: Tue 15 Jul, 2025 | 15:29:35
NSE
1,950.7024.60 (1.28%)
24.60 (1.28%)Volume9.90 L
Updated: Tue 15 Jul, 2025 | 15:53:09
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Lupin Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4,673.31 | 4,621.37 | 1.12% | 4,432.65 | 5.43% |
| Depreciation/ Amortization | 271.45 | 256.92 | 5.66% | 257.20 | 5.54% |
| Operating Income | 1,094.40 | 1,051.36 | 4.09% | 764.76 | 43.10% |
| Net Income | 855.16 | 852.58 | 0.30% | 613.12 | 39.48% |
| Other Operating Expenses Total | 1,695.92 | 1,666.99 | 1.74% | 1,560.13 | 8.70% |
| Net Income Before Taxes | 1,071.27 | 1,054.86 | 1.56% | 736.10 | 45.53% |
| Total Revenue | 5,767.71 | 5,672.73 | 1.67% | 5,197.41 | 10.97% |
| Selling/ General/ Admin Expenses Total | 984.39 | 1,007.52 | -2.30% | 889.24 | 10.70% |
| Diluted Normalized EPS | 18.69 | 18.64 | 0.28% | 13.41 | 39.37% |